Literature DB >> 17079975

Pharmacotherapy of osteoarthritis.

Todd P Stitik1, Eric Altschuler, Patrick M Foye.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17079975     DOI： 10.1097/01.phm.0000245512.85085.a0

Source DB:  PubMed          Journal:  Am J Phys Med Rehabil        ISSN： 0894-9115            Impact factor:   2.159


× No keyword cloud information.
  6 in total

Review 1.  Non-surgical management of early knee osteoarthritis.

Authors:  Elizaveta Kon; Giuseppe Filardo; Matej Drobnic; Henning Madry; Mislav Jelic; Niek van Dijk; Stefano Della Villa
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-10-25       Impact factor: 4.342

2.  Tramadol for osteoarthritis.

Authors:  Karine Toupin April; Jacinthe Bisaillon; Vivian Welch; Lara J Maxwell; Peter Jüni; Anne Ws Rutjes; M Elaine Husni; Jennifer Vincent; Tania El Hindi; George A Wells; Peter Tugwell
Journal:  Cochrane Database Syst Rev       Date:  2019-05-27

Review 3.  Glucosamine for osteoarthritis: biological effects, clinical efficacy, and safety on glucose metabolism.

Authors:  Juan Salazar; Luis Bello; Mervin Chávez; Roberto Añez; Joselyn Rojas; Valmore Bermúdez
Journal:  Arthritis       Date:  2014-02-11

4.  Anti-inflammatory effects of an injectable copolymer of fatty acids (Ara 3000 beta®) in joint diseases.

Authors:  Catherine Baugé; Eva Lhuissier; Nicolas Girard; Céline Quesnelle; Gérard Ewert; Karim Boumediene
Journal:  J Inflamm (Lond)       Date:  2015-02-23       Impact factor: 4.981

Review 5.  The Diagnosis and Therapy of Degenerative Knee Joint Disease: Expert Consensus from the Chinese Pain Medicine Panel.

Authors:  Dong Huang; Yan-Qing Liu; Li-Shuang Liang; Xue-Wu Lin; Tao Song; Zhi-Gang Zhuang; Suo-Liang Wang; Hong-Guang Bao; Lin Wang; Xian-Wei Zhang; Zhi-Gang Cheng; Bao-Lin Duan; Wei-Dong Qiu; Yuan-Chang Xiong; Jin-Feng Liu
Journal:  Pain Res Manag       Date:  2018-12-13       Impact factor: 3.037

6.  Cost-effectiveness analysis for joint pain treatment in patients with osteoarthritis treated at the Instituto Mexicano del Seguro Social (IMSS): Comparison of nonsteroidal anti-inflammatory drugs (NSAIDs) vs. cyclooxygenase-2 selective inhibitors.

Authors:  Iris Contreras-Hernández; Joaquín F Mould-Quevedo; Rubén Torres-González; María Victoria Goycochea-Robles; Reyna Lizette Pacheco-Domínguez; Sergio Sánchez-García; Juan Manuel Mejía-Aranguré; Juan Garduño-Espinosa
Journal:  Cost Eff Resour Alloc       Date:  2008-11-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.